Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
J Tradit Chin Med. 2020 Dec;40(6):891-896. doi: 10.19852/j.cnki.jtcm.20200902.001.
To summarize the evidence from Traditional Chinese Medicine (TCM) practice in the treatment of coronavirus disease 2019 (COVID-19) and provide timely clinical practice guidance.
The guidelines were developed in accordance with the World Health Organization rapid guideline process. The evidence on TCM for COVID-19 from published guidelines, direct and indirect published clinical evidence, first hand clinical data, and expert experience and consensus were collected. The grading of recommendations assessment, development and evaluation (GRADE) method was used to grade the evidence and make the recommendations.
Based on the available evidence, the guidelines recommended 17 Chinese medicines for COVID-19: 2 Chinese herbal granules, 7 Chinese patent medicines, and 8 Chinese herbal injections.
As the literature search was conducted on March, any subsequent versions of these guidelines require an up-to-date literature review. We hope that the evidence summary in these will be helpful in global efforts to address COVID-19.
总结中医药治疗 2019 冠状病毒病（COVID-19）的实践证据，为临床实践提供及时的指导。
本指南的制定符合世界卫生组织快速指南制定流程。收集了已发表指南、直接和间接发表的临床证据、第一手临床数据以及专家经验和共识中关于 COVID-19 的中医药证据。使用推荐评估、制定与评价（GRADE）方法对证据进行分级并提出推荐意见。
根据现有证据，指南推荐了 17 种治疗 COVID-19 的中药：2 种中药颗粒剂、7 种中药成药和 8 种中药注射剂。
由于本次文献检索截止到 3 月，因此后续版本的指南需要进行最新的文献综述。我们希望这些指南中的证据总结将有助于全球应对 COVID-19 的努力。
